InflaRx N.V.
Long

IFRX Biotech

111
This company develops anti-inflammatory drugs and is expected to release data soon. I anticipate more growth to mid 60's in the coming months

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.